BACIL Pharma Ltd Q4FY23 loss at Rs. 7.61 lakhs

BACIL PHARMA LTD. has reported Standalone financial results for the period ended March 31, 2023.

Financial Results (Q4 FY2023) - QoQ Comparison

The company has reported total income of Rs. 0.0085 crores during the period ended March 31, 2023 as compared to Rs. 0.0020 crores during the period ended December 31, 2022.

The company has posted net profit / (loss) of Rs. -0.0761 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs. -0.0445 crores for the period ended December 31, 2022.

The company has reported EPS of Rs. -0.13 for the period ended March 31, 2023 as compared to Rs. -0.08 for the period ended December 31, 2022.

Financials	Q4 FY2023	Q3 FY2023	% Change
Total Income	₹0.0085 crs	₹0.0020 crs	325.00%
Net Profit	₹-0.0761 crs	₹-0.0445 crs	71.01%
EPS	₹-0.13	₹-0.08	62.50%

Financial Results (Q4 FY2023) - YoY Comparison

The company has reported total income of Rs.0.0085 crores during the period ended March 31, 2023 as compared to Rs.0.0083 crores during the period ended March 31, 2022.

The company has posted net profit / (loss) of Rs.-0.0761 crores for the period ended March 31, 2023 as against net profit / (loss) of Rs.-3.7366 crores for the period ended March 31, 2022.

The company has reported EPS of Rs.-0.13 for the period ended March 31, 2023 as compared to Rs.-6.34 for the period ended March 31, 2022.

Financials	Q4 FY2023	Q4 FY2022	% Change
Total Income	₹0.0085 crs	₹0.0083 crs	2.41%
Net Profit	₹-0.0761 crs	₹-3.7366 crs	97.96%
EPS	₹-0.13	₹-6.34	97.95%

Financial Results (Year Ended FY2023) - YoY Comparison

The company has reported total income of Rs.0.1146 crores during the Financial Year ended March 31, 2023 as compared to Rs.0.0576 crores during the Financial Year ended March 31, 2022.

The company has posted net profit / (loss) of Rs.-0.1019 crores for the Financial Year ended March 31, 2023 as against net profit / (loss) of Rs.-3.8598 crores for the Financial Year ended March 31, 2022.

The company has reported EPS of Rs.-0.17 for the Financial Year ended March 31, 2023 as compared to Rs.-6.55 for the Financial Year ended March 31, 2022.

Financials	Year Ended FY2023	Year Ended FY2022	% Change
Total Income	₹0.1146 crs	₹0.0576 crs	98.96%
Net Profit	₹-0.1019 crs	₹-3.8598 crs	97.36%
EPS	₹-0.17	₹-6.55	97.40%

Shares of BACIL PHARMA LTD. was last trading in BSE at Rs. 6.15 as compared to the previous close of Rs. 5.88. The total number of shares traded during the day was 428 in over 10 trades.

The stock hit an intraday high of Rs. 6.15 and intraday low of 5.60. The net turnover during the day was Rs. 2627.00.

Source : Equity Bulls

Keywords

BACILPharma Q4FY23 FY2023 ResultUpdate